Liver Injury After CAR T-Cell Therapy May Be Driven by Cytokine Storm, Landmark Analysis Finds
A pharmacovigilance analysis of nearly five million adverse-event reports finds that liver injury after CAR T-cell therapy is predominantly early ...
A pharmacovigilance analysis of nearly five million adverse-event reports finds that liver injury after CAR T-cell therapy is predominantly early ...
A two-stage analysis combining FDA adverse event reports with Japanese claims data found aripiprazole associated with a significantly lower risk ...
An analysis of six years of FDA adverse event reports finds disproportionately high reporting odds of hair loss among patients ...
A large pharmacovigilance analysis of over 30,000 adverse event reports confirms riociguat's known risks and uncovers new safety signals, including ...
A pharmacovigilance analysis of US and Japanese adverse event databases finds that PD-1 and PD-L1 checkpoint inhibitors show a robust, ...
A sweeping analysis of more than 21,500 FDA adverse event reports has mapped which anticancer drugs most strongly trigger hand-foot ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine